BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eissa MM, El-Azzouni MZ, El-Khordagui LK, Abdel Bary A, El-Moslemany RM, Abdel Salam SA. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni. Acta Trop 2020;212:105714. [PMID: 32950482 DOI: 10.1016/j.actatropica.2020.105714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Paulino ÉT, Ribeiro de Lima M, Viçosa AL, Silva CHD, Salomon CJ, Real DA, Leonardi D, Mello Silva CC, Moraes Neto AHAD. The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models. Front Public Health 2022;10:848633. [DOI: 10.3389/fpubh.2022.848633] [Reference Citation Analysis]
2 Mengarda AC, Iles B, F Longo JP, de Moraes J. Recent trends in praziquantel nanoformulations for helminthiasis treatment. Expert Opin Drug Deliv 2022. [PMID: 35264036 DOI: 10.1080/17425247.2022.2051477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Yu QF, Zhang JY, Sun MT, Gu MM, Zou HY, Webster JP, Lu DB. In vivo praziquantel efficacy of Schistosoma japonicum over time: A systematic review and meta-analysis. Acta Trop 2021;222:106048. [PMID: 34273315 DOI: 10.1016/j.actatropica.2021.106048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]